Entrepreneurial professional with 25+ years of finance and operating experience, including in life sciences. Trained in financial modeling and accounting in investment banking and private equity. Executed middle market LBO and growth equity investments and served on Boards of Directors at several portfolio companies. Held C level operating positions with full P&L responsibility at private equity backed, middle market companies.

Serial Entrepreneur, Investor, and Board Member with an extensive and demonstrated history of excelling in firms operating in Professional Services, Healthcare, and Technology industries. Extensive corporate development & business development experience coupled with corporate legal transactional expertise in domestic and international deals in healthcare, technology, professional services, and telecommunications.

Jacques is an experienced entrepreneur with over 25 years of experience developing and managing successful initiatives in the U.S. and emerging markets, including in over 20 countries in Sub-Saharan Africa. Mr. Walker’s career highlights include co-founding and helping build companies in the biotechnology, information technology, and energy sectors. He began his career at Procter & Gamble.

Adam has 22 years of pharmaceutical industry experience spanning all phases of clinical and nonclinical drug development. As VP of Early Development and Regulatory Affairs at Prelude Therapeutics, Adam built the regulatory department, successfully submitted and opened seven INDs in oncology, contributed to the growth of the clinical organization, and served as interim toxicology and clinical pharmacology lead.

Dr. Paul Nguyen is an internationally recognized expert in prostate cancer clinical care and research. He has published over 350 original research articles and has national leadership as the vice-chair of the ARS/ACR Appropriateness Criteria Committee for Prostate Cancer and Chair of the Program Committee for the 2019 ASTRO/SUO/ASCO Genitourinary Cancers Symposium.